19th IMS Annual Meeting
AUGUST 25-27, 2022 | LOS ANGELES, CALIFORNIA
Join me at the 19th International Myeloma Society Annual Meeting!
I'm excited to speak at the 19th IMS Annual Meeting in Los Angeles, California!
Meet the Expert/Professor, Bone disease control in Myeloma
About Ramon Garcia-Sanz:
Ramón García-Sanz is hematologist at the University Hospital of Salamanca since 1994, Head of the Molecular Laboratory Unit since April 2019. He works as researcher at the Cancer Research Center of Salamanca since 2001 and is associated professor at the University since 2007. His thesis was about multiple myeloma biology, and he was awarded with a Special Mention 1993/94. He pursued postdoctoral studies in the Immunology Department of the Erasmus University of Rotterdam, The Netherlands. Dr. García-Sanz is principal investigator and co-investigator in a number of studies in Hodgkin lymphoma, Waldenström macroglobulinemia and Multiple Myeloma. He also researches in blood biology and standardization in the hematology laboratory. Ramón García-Sanz has authored 335 original research articles indexed in PubMed, as well as publications in Spanish, with more than 23,000 citations and an H index of 76 in google.scholar (or 68 in WOS). He actively participates in the Spanish groups GEM/PETHEMA and GELTAMO focusing on myeloma biology, minimal residual disease detection and global studies in Waldenström macroglobulinemia and Hodgkin lymphoma. In addition, he is the current President of the Spanish Society of Hematology.
About Our Meeting
The International Myeloma Society Annual Meeting is the defining meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects, including:
- Scientific Programs
- Keynote Addresses
- Poster Presentations
- Oral Presentations (Basic Biology, Preclinical Trials and Clinical Studies)
Testimonials
“I’ve already come away with so many great ideas from the interactions and discussions here in Vienna. You just can’t get that any other way. It's what’s been missing for the past 2 years!”
STEVEN P. TREON, MD, PhD, FACP, FRCP
Dana Farber Cancer Institute
Boston, MA
“The 18th International Myeloma Workshop in Vienna. A milestone. Immunotherapies definitely revolutionize the treatment and challenge autologous transplantation. A very special congress I will always remember.”
LAURENT GARDERET, MD, PhD
Sorbonne Université, APHP
Paris, France
Join Us in Los Angeles
